Venture Capital
BOSTON, April 11, 2019 /PRNewswire/ -- Intrinsic Therapeutics, Inc., a medical device company focusing on surgeries to treat leg and low back pain resulting from ruptured lumbar discs with large anular defects, today announced a $52m Series Growth equity financing. Questa Capital led the...

In this article